Citi: "Biosecurity Law" Uncertainty Affects Investor Confidence in the CXO Sector

Zhitong
2024.09.10 07:15

Citigroup's report states that the US House of Representatives passed the "Biological Safety Act", but it is currently unclear whether the US Senate will adopt the House version of the "Biological Safety Act" or another version, or add a larger bill to the "Biological Safety Act". The bank believes that the stock prices of WuXi AppTec and WuXi Biologics are undervalued, but uncertainties are affecting investors' confidence in the CXO sector

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.